Correlation Between Coya Therapeutics, and BridgeBio Pharma
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and BridgeBio Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and BridgeBio Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and BridgeBio Pharma, you can compare the effects of market volatilities on Coya Therapeutics, and BridgeBio Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of BridgeBio Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and BridgeBio Pharma.
Diversification Opportunities for Coya Therapeutics, and BridgeBio Pharma
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Coya and BridgeBio is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and BridgeBio Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BridgeBio Pharma and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with BridgeBio Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BridgeBio Pharma has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and BridgeBio Pharma go up and down completely randomly.
Pair Corralation between Coya Therapeutics, and BridgeBio Pharma
Given the investment horizon of 90 days Coya Therapeutics, Common is expected to generate 1.36 times more return on investment than BridgeBio Pharma. However, Coya Therapeutics, is 1.36 times more volatile than BridgeBio Pharma. It trades about 0.02 of its potential returns per unit of risk. BridgeBio Pharma is currently generating about -0.01 per unit of risk. If you would invest 696.00 in Coya Therapeutics, Common on September 3, 2024 and sell it today you would lose (62.00) from holding Coya Therapeutics, Common or give up 8.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Coya Therapeutics, Common vs. BridgeBio Pharma
Performance |
| Timeline |
| Coya Therapeutics, Common |
| BridgeBio Pharma |
Coya Therapeutics, and BridgeBio Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Coya Therapeutics, and BridgeBio Pharma
The main advantage of trading using opposite Coya Therapeutics, and BridgeBio Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, BridgeBio Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma will offset losses from the drop in BridgeBio Pharma's long position.| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
| BridgeBio Pharma vs. Blueprint Medicines Corp | BridgeBio Pharma vs. Amylyx Pharmaceuticals | BridgeBio Pharma vs. Day One Biopharmaceuticals | BridgeBio Pharma vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |